Masciullo, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 1.199
EU - Europa 955
AS - Asia 752
SA - Sud America 144
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.078
Nazione #
US - Stati Uniti d'America 1.171
SG - Singapore 365
PL - Polonia 219
DE - Germania 183
IT - Italia 168
CN - Cina 138
BR - Brasile 119
SE - Svezia 114
VN - Vietnam 81
FR - Francia 65
GB - Regno Unito 36
IN - India 35
UA - Ucraina 35
IE - Irlanda 33
RU - Federazione Russa 27
ID - Indonesia 23
TR - Turchia 23
FI - Finlandia 19
BD - Bangladesh 17
CA - Canada 13
BE - Belgio 12
AR - Argentina 10
IQ - Iraq 10
ZA - Sudafrica 10
HK - Hong Kong 9
JP - Giappone 8
MX - Messico 7
CZ - Repubblica Ceca 6
PK - Pakistan 6
AT - Austria 5
KR - Corea 5
NL - Olanda 5
UZ - Uzbekistan 5
CL - Cile 4
EG - Egitto 4
ES - Italia 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CI - Costa d'Avorio 3
IR - Iran 3
JO - Giordania 3
RO - Romania 3
SA - Arabia Saudita 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EC - Ecuador 2
GR - Grecia 2
HU - Ungheria 2
LT - Lituania 2
MA - Marocco 2
PE - Perù 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.078
Città #
Singapore 226
Warsaw 218
Chandler 174
San Jose 115
Ashburn 108
New York 50
Ann Arbor 45
Fairfield 45
Beijing 34
Dublin 33
Wilmington 31
Milan 28
Houston 26
Woodbridge 25
Ho Chi Minh City 24
Rome 24
Cambridge 23
San Mateo 23
Jacksonville 22
Los Angeles 22
Jakarta 21
Cattolica 19
Hanoi 18
Izmir 18
Seattle 18
Lauterbourg 17
Council Bluffs 15
Moscow 15
Boston 14
Frankfurt am Main 14
Dallas 13
Brussels 12
Hyderabad 12
Hefei 11
Chicago 10
Dearborn 10
Princeton 10
The Dalles 10
Munich 9
Santa Clara 9
São Paulo 9
Augusta 8
Helsinki 8
Hong Kong 8
Marseille 8
Nanjing 8
Nürnberg 8
Boardman 7
Düsseldorf 7
Lawrence 7
Toronto 7
Da Nang 6
Dong Ket 6
London 6
Orem 6
Redwood City 6
Rio de Janeiro 6
Tokyo 6
Bremen 5
Kent 5
Lancaster 5
Mentana 5
Nanchang 5
Norwalk 5
Nuremberg 5
Seoul 5
Acton 4
Belo Horizonte 4
Chennai 4
Curitiba 4
Fremont 4
Haiphong 4
Johannesburg 4
Melfi 4
Nairobi 4
Prague 4
Recife 4
Shenyang 4
St Louis 4
Tashkent 4
University Park 4
Zhengzhou 4
Abidjan 3
Amman 3
Atlanta 3
Baghdad 3
Changsha 3
Cornate d'Adda 3
Gatchina 3
Guangzhou 3
Guarulhos 3
Karachi 3
Kunming 3
Naples 3
Paris 3
Phoenix 3
Pompano Beach 3
Portsmouth 3
San Diego 3
San Francisco 3
Totale 1.856
Nome #
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 402
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 316
Expression of Pinopodes in the Endometrium from Recurrent Pregnancy Loss Women. Role of Thrombomodulin and Ezrin. 201
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 175
Cyclin E correlates with MnSOD expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy 154
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 151
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients 149
Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer 143
Effect of alpha‐lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women 142
Long-term survival of young endometrial cancer patients desiring fertility preservation treated with hysteroscopic resection followed by hormone therapy (NEMO technique) 128
Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study 128
Hysteroscopic removal of a gauze inadvertently retained in uterus for two years following caesarean section. 125
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 123
Nuclear Expression of β-Catenin Is Associated with Improved Outcomes in Endometrial Cancer 117
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 112
Emerging drugs for endometrial cancer 108
The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis 103
Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins 103
Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors 99
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate 94
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability 58
Totale 3.131
Categoria #
all - tutte 12.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022202 25 15 2 18 12 8 1 30 11 17 32 31
2022/2023426 48 56 34 76 16 60 13 43 52 4 21 3
2023/2024229 6 62 7 8 10 44 14 13 4 10 16 35
2024/2025371 9 11 41 5 42 12 17 13 33 52 91 45
2025/20261.038 142 40 57 93 158 56 186 53 114 88 28 23
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 3.131